Ondasetron Hikma (Ondansetron)

Ondansetron, the active ingredient in Ondasetron Hikma, is a serotonin 5-HT3 receptor antagonist presented as a tablet for oral use. It is used to prevent nausea and vomiting associated with chemotherapy, radiation therapy, and surgery in adult and pediatric patients.

GNH USA supplies Ondasetron Hikma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

Ondansetron acts on the serotonergic pathway to control nausea and vomiting. It is indicated for: - Chemotherapy-induced nausea and vomiting (CINV): helps reduce the frequency and severity of nausea and vomiting caused by cytotoxic drugs. - Radiation-induced nausea and vomiting (RINV): provides relief from nausea and vomiting that occur during or after radiotherapy. - Post‑operative nausea and vomiting (PONV): reduces the incidence of nausea and vomiting following surgical procedures.

Common Side Effects: - Headache: mild to moderate headache reported. - Constipation: reduced bowel movements. - Diarrhoea: loose stools. - Fatigue: feeling of tiredness. - Dizziness: light‑headed sensation. - Injection site reactions (if applicable): mild pain or erythema.

Serious or Rare Side Effects: - Cardiac arrhythmia: QT‑interval prolongation leading to irregular heart rhythm. - Severe allergic reaction: anaphylaxis, angioedema, or urticaria. - Serotonin syndrome: rare but potentially life‑threatening when combined with other serotonergic agents. - Hepatic dysfunction: elevated liver enzymes. - Severe constipation or intestinal obstruction. - Neuroleptic malignant‑like syndrome: extremely rare neurological emergency.

Before using Ondasetron Hikma, consider the following precautions: - Cardiac monitoring: patients with known QT prolongation or electrolyte imbalance should be monitored. - Electrolyte assessment: correct potassium or magnesium deficiencies prior to therapy. - Drug interactions: review concomitant medications that may affect cardiac rhythm. - Pregnancy: use only if the potential benefit justifies the risk to the fetus. - Breastfeeding: assess risk versus benefit as the drug may pass into milk. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Ondansetron may interact with several medications. Review the following: Major Interactions (Avoid): - Apatinib: may increase the risk of QT prolongation. - Certain pharmac​ ‑   ---

Moderate Interactions (Monitor Closely): - Ond  --- -  --- -  --- -  --- - ​ ---